From: Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter
Characteristics | No. of Patients (%) |
---|---|
Sex | |
Male | 42 (87.8) |
Female | 6 (12.2) |
Age | 66.1 (41–87) |
Tumor size (mm) | 55.1 (10–147) |
Center of the tumor from EGJ (mm) | |
Median (range) | + 4.8 (−12.5 to + 20) |
pT category | |
T1a or b | 11 (22.9) |
T2 | 18 (37.5) |
T3 or T4 | 19 (39.6) |
pN category | |
N0 | 18 (37.5) |
N1 | 15 (31.3) |
N2 | 10 (20.8) |
N3 | 5 (10.4) |
Number of metastatic lymph nodes | |
Median (range) | 5.3 (0–39) |
lymphovascular invasion | |
Negative | 7 (14.6) |
Positive | 41 (85.4) |
Approach | |
Right transthoracic | 4 (8.3) |
Left transthoracic | 17 (35.4) |
Transhiatal | 27 (56.3) |
Type of esophageal resection | |
Total/subtotal esophagectomy | 5 (10.4) |
Lower/abdominal esophagectomy | 43 (89.6) |
Type of gastric resection | |
Total gastrectomy | 24 (50.0) |
Proximal gastrectomy | 24 (50.0) |